From now on, accredited General Practices will need to employ at least one Registered Veterinary Nurse (RVN), whilst at Veterinary Hospitals all patients should now have a nursing plan in place, and an RVN will need to be on duty at all times.
Other changes to the PSS requirements include:
The full list of changes to the Practice Standards Scheme, together with the new module and award documents, can be found at: www.rcvs.org.uk/PSSreview.
David Ashcroft leads the team of PSS Assessors responsible for undertaking practice visits and assessing if they meet the required standards. He said: “The changes will come into force later in the year, at the same time as we are planning to return to in-person assessments, and so timings will be subject to government guidance on coronavirus and the easing of lockdown restrictions.
“As the PSS returns to in-person assessments, practices will have the usual three-month period between booking the assessment and the assessment taking place with which to familiarise themselves with the changes and the modules documents relevant to their accreditation.
“If anyone has any questions about the changes then please make sure to contact the Practice Standards Team on pss@rcvs.org.uk and we will be happy to help in any way we can.”
Jane, who has also just been appointed to chair IVC's Small Animal Clinical Board, was awarded the certification in recognition of her dedication to professional development, having achieved 180 post graduate points for the Masters level award.
Jane already holds a PG certificate in Emergency Medicine and Surgery, a postgraduate diploma in Advanced Veterinary Practice Sciences, GP certificates in Small Animal Surgery and Advanced Small Animal Orthopaedic Surgery and a Focus Certificate in Veterinary Arthroscopy.
She is also an RCVS advanced practitioner in small animal surgery and in emergency medicine and critical care and is currently studying for further certifications in pain management and small animal musculoskeletal ultrasound.
Jane said: "I have always loved learning, and CPD has been incredibly important throughout my career to date.
"I’ve worked hard over the last 35 years to gain additional qualifications and to take advantage of every development opportunity I could to build on my own knowledge and capabilities.
“I very much look forward to sharing this experience and working with the rest of the board to support our small animal colleagues across IVC Evidensia in providing the best possible standards of care.”
MDC Exports is launching a cat cage at BSAVA Congress which it claims will revolutionise the way cats are cared for in veterinary surgeries
According to the company, plastic cages currently in use tend to harbour germs where cats have made scratches in their surfaces. This cage, however, is the first of its kind to be made from stainless steel, which cats' claws cannot damage.
MDC claims the hygienic Cat Cage will protect animals from disease and infection during their stay in surgery making for happier, healthier patients. The company says the stainless steel Cat Cage is strong, durable and can be flame sterilized. The handles can also be colour-coded, for example, yellow means neuter, red means post-anaesthetic and green means ready to go home. Each stainless steel Cat Cage also comes with a two-year free replacement guarantee.
For more information, visit MDC Exports at BSAVA Congress 2011 on stand 123. All visitors to the stand will receive a complimentary NipLok - the quick-release tourniquet that can be operated one-handed
SureFlap, a microchip pet product company, will be launching SureFeed, a new automatic cat feeder at the London Vet Show, Stand L32, on the 21st - 22nd November 2013.
The company, which already sells a range of microchip-operated pet doors, says the new products are designed to keep food fresh and the kitchen free of smells and flies.
SureFeed will be available in two models: the SureFeed Pet Feeder, which opens when any pet approaches, and the SureFeed Microchip Pet Feeder which in addition functions as a selective pet feeder that opens only when it identifies a cat with a registered microchip or RFID collar tag.
Both products feature a bowl which seals shut to keep wet food fresh.
Dr Nick Hill, inventor of SureFeed as well as founder and inventor of SureFlap says this is an exciting new development for the company: "Many cats are fussy eaters and prefer to eat food when it is fresh, others are on special diets and this can be a problem in multi-pet households. Even in households where each cat is on the same diet, a 'greedy' cat, or even dog, can eat most of the food. This can result in one pet becoming overweight while the other starts to lose condition. The SureFeed product range has been designed to address all these issues."
The SureFeed Microchip Pet Feeder recognises a cat's unique microchip number and when an authorised cat is present, the sealed lid over the bowl slides back to reveal the food. Once the cat has left the feeder, the lid slides back over the bowl. The SureFeed Pet Feeder features the same sealed lid which is triggered to open by any approaching pet, closing again when the pet has finished feeding.
Nick said: "The SureFeed product range is the culmination of two years' intensive development work. The feeders incorporate a number of features to maximise usability, such as the Microchip Pet Feeder's side guards and lid which folds up to the rear, which shield the food from other pets while the authorised cat is eating. The feeders are both easy to wipe clean and the food bowl, mat and lid can be removed and are dishwasher-safe.
"The SureFeed Pet Feeder and Microchip Pet Feeder are the first in a suite of pet feeding products from SureFlap incorporating sealed operation and flexible feeding options and we are looking forward to developing the range in the future."
SureFeed products will be available to order from early 2014 but in the meantime, you can see them in action at Stand L32 at the London Vet Show.
The expert panel consisted of Peter Sandøe (Denmark), Professor of Ethics and Welfare; Helle Friis Proschowsky (Denmark), a veterinary surgeon working with the Danish Kennel Club; Laurent Findji (France/UK), Specialist in Soft Tissue Surgery; Gudrun Ravetz (UK) – Senior Vice President, British Veterinary Association; Kristin Wear Prestrud (Norway) – Veterinary Scientific Director of the Norwegian Kennel Club and Åke Hedhammar (Sweden), Professor Emeritus in Internal Medicine (companion animals), a veterinary consultant for the Swedish Kennel Club and a member of the WSAVA Hereditary Disease Committee.
Kristin Wear Prestrud said: "Vets should dare to speak out. We must educate owners on all health and welfare matters, whether we are simply advising them that their dog is overweight or if we need to give advice on breeding or refuse planned Caesarean sections."
The panel's recommendations are:
At a practice level, veterinary professionals should:
At an organisational level, the veterinary profession should:
Photo: ponpimonsa_bibi/Shutterstock
The AHT has published the first research paper of its kind which looks at idiopathic epilepsy (IE) in the Italian Spinoni, a breed where the prevalence of IE has been found to be 5.3%, compared to 0.6% estimated to be seen in dogs generally in UK first opinion practice.
Dr Luisa De Risio, Head of Neurology at the AHT and lead researcher on the paper, said: "Idiopathic epilepsy is the most common chronic neurologic disorder in dogs but it can be more common in some breeds than others, for example Irish Wolfhounds, Border Collies and Italian Spinoni. Sadly, we see a lot epileptic dogs in our clinic, including these breeds as well as Golden Retrievers and Labrador Retrievers, so research being undertaken at the AHT, and around the world, is very important in helping owners of dogs with epilepsy to be able to control the effects of the disease.
"The Italian Spinone is a wonderful breed but is highly affected by idiopathic epilepsy. To our knowledge, no one has conducted such a large-scale research study in this breed to be able to gain a better understanding of how the epilepsy manifests, how prevalent it really is and, importantly, which factors may contribute to survival in these dogs.
"With the backing of the Italian Spinone Club of Great Britain, the AHT was able to design a questionnaire for the research study and work with the Kennel Club to invite over 3,000 Kennel Club registered Italian Spinone owners to aid our research by completing the questionnaire.
"1,192 owners participated in the research and of this sample, 63 Italian Spinoni had IE. Owners of affected dogs were then invited to complete a further questionnaire and asked to make the dog's medical records available. This gave us a very large amount of data to analyse from which we were able to glean a lot of very useful information about the clinical characteristics of idiopathic epilepsy in Italian Spinoni."
The research also looked at survival times of those dogs in the study with IE. Survival was significantly longer in Italian Spinone with no cluster seizures and in Italian Spinone in which antiepileptic medication was initiated after the second seizure rather than after more than three seizures.
Luisa continued: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs.
"The input in treatment design and modulation by a specialist veterinary neurologist with expertise in canine epilepsy can help to optimise treatment success and the dog's quality of life.
"We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE.
"Epilepsy is one of the most complex and difficult diseases to treat, with several variables in any case, but it is important for owners not to give up hope and to seek a consultation with a veterinary neurologist who specialises in epilepsy, if possible."
The next phase of the AHT's research in the Italian Spinone is to identify the genetic basis of this condition, with the aim of identifying the genetic mutations responsible so that a genetic test could be created. This research is currently on-going in Italian Spinoni and Border Collies and requires more DNA samples from affected and unaffected dogs.
Luisa said: "A genetic test is the only way to successfully help breeders identify carriers and select matings which are most likely to produce unaffected dogs. However, the genetics, like the condition itself, are very complex so the development of such a test is still likely to be many years away. The most we can do for these lovely dogs now is to share these findings across the veterinary profession and to do our best to treat each dog as well as we can."
The full paper is titled 'Idiopathic Epilepsy in the Italian Spinone in the United Kingdom: Prevalence, Clinical Characteristics, and Predictors of Survival and Seizure Remission' and is published in the Journal of Veterinary Internal Medicine on an open-access basis.
Photo: © Caroline Granycome
Propomitor can be used for the induction and maintenance of general anaesthesia for procedures lasting up to five minutes by the administration of incremental doses or as a constant rate infusion (CRI).
It can also be used for the induction of general anaesthesia where maintenance is provided by the inhalation of anaesthetic agents.
Animalcare Product Manager Kai Crawshaw said: "Propofol is the ‘go to’ solution for short-acting anaesthesia in many practices so we are delighted to add Propomitor, our new affordable propofol solution, to our range. It complements our already extensive anaesthetic toolkit, which offers options for analgesia, sedation, gaseous anaesthesia and recovery."
Propomitor is available in boxes of 5 x 20 ml bottles.
For more information, contact your Animalcare Territory Manager or Animalcare’s head office on 01904 487687.
Merial Animal Health has been found in breach of the NOAH Code of Practice for literature promoting the wormer Ivomec Super.
In the literature, Merial stated that Closantel injection (Janssen Animal Health) was effective against flukes aged 9 weeks or older, when in fact, at the time the undated brochure was distributed, Closantel was effective against flukes aged 7 weeks or older.
Merial did not dispute the facts alleged: the company had relied on an out-of-date detailer. The NOAH Code of Practice Committee emphasised the need for members to ensure, when giving comparative data in promotions, that up-to-date data is used. The SPC of any authorised product can be viewed on the VMD's website.
The Committee did commend Merial Animal Health for taking corrective action within two days of notification by the Complainant.
NOAH encourages those interested in finding out more to read the full details of the Committee's rulings on the NOAH website at www.noah.co.uk/code.
There were 22,000 nominations for this year's awards, which will be held at the Kimpton Clocktower Hotel in Manchester on 24th March.
Other finalists are:
Vet Nurse of the Year
Practice of the Year
Practice Support Staff of the Year
Practice Manager of the Year
James Barnes, head of sales and partnerships at Petplan, said: “We’re delighted to announce the finalists for this year’s Veterinary Awards.
"The awards celebrate the dedication and brilliant work carried out by some of the UK’s very best veterinary professionals.
"Congratulations to all the 2022 finalists on this fantastic achievement."
For further information on the awards visit www.petplanvet.co.uk.
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
References
A new book written by a man who is both married to and brother of a veterinary surgeon (not the same one, I hasten to add), offers a husband's take on a vet's life.
Author Steve Ankers is married to Margaret Ankers MRCVS (Acorn Veterinary Surgery) and brother of John Prescott MRCVS (now retired, but remains a consultant to Robson & Prescott).
His book, called It's a Dog's Life for the Other Half, is brimfull of funny anecdotes, including: holding hands with a famous actress inside a cow's rectum; a dog who ate a Cliff Richard cassette; a cat who ate a Chihuahua but spat out the tail and a vulture who travelled hundreds of miles on a car roof-rack.
Terry Jones (you know, the Python) described the book as "Hilarious and eminently readable".
It's a Dog's Life for the Other Half may be the literary equivalent of a busman's holiday for the members of this site, but I'm half way through and it's one of those rare books that's guaranteed to bring a smile to your face at least once a page.
It's a Dog's Life for the Other Half is available now from all good bookshops, including Amazon RRP £12.99. It is also available as an e-book.
Ceva Animal Health UK has launched a new Galastop iPhone application to calculate the optimal date for spaying in order to reduce the risk of post-operative false pregnancy.
Enter the end of oestrus date (when the last season finished), and the app will calculate when to spay, i.e. 16 weeks later.
Ceva says it is important not to spay a bitch during a false pregnancy as post-operative chronic pseudopregnancy may develop, which can last longer and be more resistant to standard treatment. However, some cases of false pregnancy can be silent and difficult to detect. Product manager at Ceva Animal Health UK, Fraser Broadfoot MRCVS, said: "It is commonly recommended to wait until 12 weeks after the end of oestrus before spaying. However, silent pseudopregnancy can still occur at this stage so, to be on the safe side, many specialists are now recommending spaying later at 16 weeks after the end of oestrus."
Click here for more details, and to download the app in iTunes.
For further information, please contact your Ceva Animal Health UK representative or call the veterinary support team on 01494 781510.
MSD has announced that the broad-spectrum clostridial disease vaccine for sheep and cattle, Bravoxin 10, is now available in a new 6 x 100ml farm vaccination pack. The pack contains enough vaccine for 600 sheep or 300 cattle boosters.
Buyers of the new farm pack will also get a free vaccine applicator worth £20. The new Bravoxin 10 applicator benefits from the sterimatic system, which protects and sterilises the vaccination needle with each injection. MSD says it can also be placed down between doses without risk of needle damage, self-injection or needing to remove the vaccine bottle.
Bravoxin 10 protects both cattle and sheep from clostridial diseases like blackleg and black disease, as well as other conditions caused by clostridial bacteria that usually kill the animal once infection has become established. The vaccine protects against disease caused by the 10 main clostridial bacteria; C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
Bayer Animal Health has launched Baytril® Max 100mg/ml Solution for Injection for Cattle and Pigs, which replaces the company's previously animal-specific Baytril Max products.
Bayer says the active ingredient, enrofloxacin, treats bacterial infection by inhibiting the action of bacterial DNA gyrase resulting in bacterial cell death.
In cattle, Baytril Max treats respiratory infections and mastitis caused by enrofloxacin-sensitive Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma spp., and enrofloxacin-sensitive E. coli respectively.
In pigs, Baytril Max targets bacterial bronchopneumonia caused by enrofloxacin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by Haemophilus parasuis as a secondary pathogen in pigs.
Bayer advises that vets treating cattle for respiratory infections should inject subcutaneously. Mastitis cases should be treated intravenously and pigs should be injected intramuscularly in the neck muscles, behind the ear.
The development of the Baytril Max product family provides vets with greater treatment flexibility from one solution.
For further information please visit www.noahcompendium.co.uk
Sponsored by Boehringer Ingelheim, the Practice Marketing Award is free to enter, and open only to veterinary practices.
Entries need to demonstrate initiative and/or innovation in the marketing of the practice's services and/or products to clients or the general public during 2017. Eligible entries for the award can include: display advertising, direct mail or electronic media, such as email or websites.
VMA Awards Chair Claire Edmunds said: "Practices have often done a much better job of marketing than they think! And even if they don’t win, entering is great experience and the awards event provides an opportunity to network in the profession. As marketing is becoming an ever more important component in practice success, we would like to encourage as many practices as possible to enter the award."
Last year’s winner Vicky Scutt, joint owner and senior vet at Whitstable Bay Veterinary Centre, said: "Winning the Practice Marketing Award is a real highlight of my career so far! Receiving such a prestigious national award for our practice marketing proves the importance of staying true to your beliefs in business. It gave us the confidence to keep to the same message - because it's clearly working!"
The deadline for submissions is of 2nd February 2018, and the awards are presented on 16th March 2018 in the newly refurbished 5-star Royal Lancaster London hotel.
To enter the Practice Marketing Award, visit: https://www.vma.org.uk/vma-award-categories/practice-marketing-award-entry/
To book event tickets, visit: http://www.vma.org.uk/events/vma-annual-advertising-awards/
For any other information, visit: www.vma.org.uk, email: secretary@vma.org.uk or telephone 0330 223 2259.
Next year, in collaboration with the International Veterinary Students’ Association (IVSA), there will be a new category to recognise a veterinary student for his or her contribution towards animal welfare.
The WVA Animal Welfare Award 2019 will be presented to six veterinary surgeons from the WVA 6 geographical regions and to one veterinary student from around the world.
The Award Ceremony will take place during the 35th World Veterinary Association Congress on 28th April 2019 in San Jose, Costa Rica where the selected winners will be invited to collect their WVA Animal Welfare Award and a prize of €5,000.
Ceva and the WVA say they are now actively studying a plan to expand the awards to include veterinary schools, rewarding them for Animal Welfare Excellence in Veterinary Education.
For more information, visit http://www.worldvet.org/news.php?item=356
As a result, clients of LV=GI and Waggel will be able to book an online appointment with a veterinary surgeon within 30 minutes, without having to pay FirstVet's normal £20-30 charge.
Waggel is FirstVet's 26th insurance partner globally, and its third in the UK. The company now has 150 veterinary surgeons working on the platform.
Lucy Broadbridge, LV= GI Pet Product Manager, said: “At LV= GI we’re always looking for ways to help our customers protect what they love, so we’re very excited to be able to work with FirstVet to provide this service to our pet customers. With access to a vet from your smartphone or device, our pet customers will have peace of mind knowing that qualified veterinary advice is on hand 24/7, avoiding unnecessary time, cost and distress of visiting their vet if they don’t really need to."
Under current legislation, there is very little practical assistance that can be offered via an online consultation, other than recommending whether or not the animal needs to be seen by a veterinary surgeon in person. It may also be the case that the online consultation offers little more than a pet owner would get by ringing their normal vet. Nevertheless, online consultations will doubtless grow significantly in 2020, as the players line up to take advantage of any relaxation in the regulations that they hope will allow veterinary surgeons to prescribe medicines for animals they have not seen in person.
Regardless of whether that happens, there is a value in face-to-face communication between a veterinary surgeon or nurse and a client, whether it be for triage or follow up consultations. Independent practices might therefore be well advised to start implementing this kind of technology in practice sooner rather than later, in particular looking at ways that online appointments could be scheduled (perhaps between normal consultations) so as to compete with the short waiting times offered by companies like FirstVet.
The two 60-minute interactive sessions are taking place on Wednesday (21st April) at 12.30pm and 6pm, coinciding with the United Nation’s World Creativity and Innovation Day.
Each session will introduce a range of creative techniques that can be used to spur innovation. Different breakout groups will then have various problems to solve and will utilise these techniques to tackle challenges and issues encountered within everyday veterinary practice.
Sophie Rogers, RCVS ViVet Manager, said: "These creativity techniques are a framework for approaching problems, but the key to developing solutions to everyday tasks and problems is learning how to foster and harness the whole team's creative abilities. These workshops will provide the techniques to help you and your team overcome the common barriers to creativity and gain the tools and mindsets needed to break existing patterns and ways of doing things, generate new ideas, and improve creative self-leadership.”
The workshops will be hosted by Gill Stevens (pictured right), the Founding Director of Level Seven, a consultancy that specialises in merging coaching with design thinking methodology as a way to support innovation and team productivity, and Rick Harris, Founder of Customer Faithful, a research-led consultancy, specialising in customer research, proposition design and employee engagement.
Veterinary professionals can sign up to the sessions, which count towards their continuing professional development (CPD) requirement, via the ViVet website at: www.vivet.org.uk/interactive-workshop-on-creative-thinking/
The company says that recent supply issues have been due to 'incredible' demand for Reconcile since it was launched in the UK in 2022, which greatly surpassed expectations.
Dr Lucy Chadwick, Head of Technical Services & Marketing at Forte Healthcare Ltd said: “We realise that the recent supply issues have been very inconvenient so we thank all of our customers for their patience and support during this challenging time.
"We are confident that our supply issues to date have been resolved and that we have enough stock going forward to meet market demand.“
www.reconcilefordogs.com
The new, four storey, architecturally-designed clinic is full of natural light and includes calming and spacious staff breakout areas.
By combining a beautiful work environment with seamless technology, the company believes it can transform working conditions and job satisfaction for vet teams.
On the tech side, the Creature Comforts has created a proprietary app which allows triage to be handled online and for staff to work flexibly.
The company says the app also reduces the administrative burden, a contributory factor for staff burnout.
Creature Comforts says most clients subscribe at a cost of £20 per pet per month, giving them unlimited consultations, instant bookings and live chat via the app (as well as annual vaccinations and discounted routine treatments).
This should mean animals are seen more frequently, and conditions can be identified and treated earlier.
Memberships will be capped to control vet team caseload and to ensure a good customer experience.
The company is also addressing Competition and Markets Authority concerns, with prices for routine treatments listed on its website, upfront estimates for procedures, and a business model hinged on unlimited access to expertise (i.e. consultations, instant in-app bookings and live chat) at no extra cost for subscribed members.
Creature Comforts says its vet team benefits from a share of their clinic’s profits, above industry-standard pay, compensated overtime, a well-balanced staffing ratio, manageable working hours and scheduled breaks.
Dr Russell Welsh, COO and co-founder of Creature Comforts, said: “It’s an incredible feeling to see a plan come together in a sector that’s so ripe for transformation.
"We want to bring the passion, joy and fun back to our profession, and this is an opportunity to do things differently and vastly better, with a fresh and carefully-considered business model founded on the principles of health and happiness.
"This is vet care as it should be."
https://www.creaturecomforts.co.uk
Sarah, who is one of twelve recognised Specialists in feline medicine working in the UK, will advise and explore the tell-tale signs of feline diabetes mellitus and how the condition is best managed.
Royal Canin says diabetes mellitus is estimated to affect around 1 in 200 cats and is the second most common endocrinopathy after hyperthyroidism. Risk factors can include gender and neuter status, lifestyle and medication history and most relevant today, obesity.
Sarah said: "The prevalence of feline diabetes mellitus is thought to be on the increase and diagnosis can be made more challenging by the stress hyperglycaemia phenomenon that cats are vulnerable to.
"By exploring and dissecting successful strategies and ways in which diabetic remission can be achieved, this webinar will hopefully assist veterinary professionals how to diagnose and manage effectively with great end results for both owner and cat."
To register for the webinar, visit: https://vetportal.royalcanin.co.uk/cpd/webinar/
With Vetscan Imagyst, samples are prepared in-clinic using traditional methods, but submitted digitally, rather than sending physical slides to a laboratory. In this way, results are available in hours, allowing vets to offer same-day diagnosis and treatment.
The company says the new digital cytology application offers fast, accurate reviews of common cytology specimens, such as fine-needle aspirates,
Jamie Brannan, President International Operations, Zoetis said: "Veterinarians have told us that Vetscan Imagyst technology helps them make better informed decisions in a more transparent way for pet owners. With the cytology feature, Vetscan Imagyst will now offer one platform for multiple tests.”
He added: “We are excited to build on the incredible momentum that began with the AI fecal analysis launch. Vetscan Imagyst has been a significant part of the Zoetis portfolio and continues to evolve to meet diagnostic needs in practices around the world. The unique all-in-one technology has added immense value to veterinary clinics, facilitating fast, more accurate results, leading to quicker diagnoses and decisions that ultimately strengthen the bond of trust between veterinarians and their clients.”
For more information, contact your Zoetis representative or visit www.vetscanimagyst.com
The RCVS Disciplinary Committee has suspended a Kent veterinary surgeon from the Register for eight months after he was found guilty of dishonest certification.
At the outset of the hearing held on 14/15 December, Takeshi Okano, of Lakeview Veterinary Centre in Deal, Kent, admitted charges that, whilst acting as Official Veterinarian, he had signed a number of certificates when he knew that did not have all the information needed to do so.
On 23 June 2009, Mr Okano had been asked to act as Official Veterinarian to examine four horses and sign the certificates necessary for their export to the USA. The certificates required Mr Okano to certify he had received a written declaration from the owners that the animals had been in the UK for 60 days previously. Mr Okano also signed certificates indicating that the horses had only been in France, Ireland, or the UK for the same 60-day period. Despite having received no such declarations, and having no information whatsoever of where the horses had been, Mr Okano signed the certificates. At the hearing, no explanation for Mr Okano's actions was offered.
Mrs Beverley Cottrell, Chairman of the Disciplinary Committee said: "The validity of any certificate is an integral part of the system relating to the export or import of animals. At Section G of the RCVS Guide to Professional Conduct, emphasis is given to the importance of certification, the importance of the signature and the guidance issued by DEFRA. These provisions are well known to the profession."
The Committee was satisfied that Mr Okano's actions in signing the certificates without the owners' declarations amounted to a serious departure from professional standards. In reaching a decision on sanction, it considered that, whilst a reprimand or warning would not be appropriate, neither would removing Mr Okano's name from the Register be proportionate, or necessary either in the public interest or to protect animals.
"Mr Okano is a young veterinary surgeon at the start of his career, who from the outset admitted his actions," said Mrs Cottrell noting that the testimonials from veterinary surgeons, veterinary nurses and clients, and his record of Continuing Professional Development demonstrated his commitment to high standards within the profession. "In reaching this decision, we have paid particular regard to the fact the false certification was neither persistent nor concealed, nor was he a senior veterinary surgeon."
The Committee directed Mr Okano's name be suspended from the Register for eight months.
MSD Animal Health has launched Zuprevo Cattle, which contains a novel antibiotic molecule to help combat bovine respiratory disease (BRD).
Zuprevo Cattle contains the active ingredient tildipirosin (180mg/ml), a new 16-membered, tribasic macrolide unique to animal health. It is licensed for the treatment and prevention of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.
According to MSD Animal Health livestock veterinary adviser Paul Williams MRCVS, the new product works extremely quickly in the animal, as well as offering the longest duration of activity in the lungs of all the macrolide antibiotics currently on the market. He says it is also extremely convenient to use: "Zuprevo is readily absorbed by the animal, reaching peak plasma concentrations within 23 minutes of injection. Zuprevo is readily distributed around the body and reaches lung concentration well above MIC90 for all of the three BRD target pathogens within four hours of administration. In addition, it maintains lung concentration above the MIC90 for up to 28 days, which will appeal to many practitioners."
Paul says that it is Zuprevo's 16-membered, tribasic macrolide structure that allows it to deliver these significant pharmacological benefits for the management of BRD in cattle: "Zuprevo works by diffusing into the bacterial cell where its binding action inhibits protein synthesis of the bacterial ribosome. Its unique 16-membered, tribasic structure enables enhanced penetration of the bacterial cell wall, as well as having the ability to bypass some potential bacterial resistance mechanisms."
Paul says Zuprevo also offers vets and their farmer clients important practical usage advantages: "Zuprevo is an easily syringeable solution for injection available in convenient 20ml, 50ml and 100ml vial sizes to suit different usage requirements. At a dose rate of 1ml/45kg, it offers the lowest macrolide dose volume per kg of bodyweight. At 47 days, Zuprevo also has the shortest macrolide meat withdrawal period."
Further information on this new macrolide antibiotic is available from the MSD Animal Health territory managers or by calling the company's Veterinary Services Group on 01908 685685.
The report, which was developed in consultation with BVA members, devolved branches, BVA specialist divisions and other stakeholders, outlines the essential role that the UK veterinary workforce plays in not only caring for animals, but in enabling trade, ensuring food hygiene and safety, and undertaking cutting-edge research.
Non-British EU veterinary surgeons are critical to the UK veterinary workforce. Around 50% of veterinary surgeons registering to practise in the UK each year come from overseas, with the vast majority of these coming from the rest of the EU. Yet one-fifth of vets are already reporting that it has become harder to recruit since the EU Referendum.
To secure the best possible outcomes for animal health and welfare, public health, and the veterinary profession, Brexit and the veterinary profession sets out 52 recommendations for the short, medium and long term, including calling on the next Government to:
BVA President Gudrun Ravetz said: "Vets provide the foundation for the UK’s work on animal health and welfare. Veterinary teams up and down the country support the UK’s 11 million pet-owning households; not a penny of the UK’s £13 billion agri-food industry could be realised without vets; and we are an integral part of the international scientific community, annually bringing in over £50 million for research and development projects.
"The veterinary profession is in a unique position from which to offer the next Government evidence-based policy recommendations to ensure animal health and welfare, public health and other standards are at the very least maintained as we exit the EU.
"We believe Brexit also presents us with opportunities, for example, to develop a strong, competitive food industry with full consumer confidence at home and abroad as well as to position the UK as a world leader in high animal welfare - and a strong veterinary workforce is vital in achieving this."
Brexit and the veterinary profession was developed and written by the BVA Brexit Working Group, under the chairmanship of Alick Simmons, former UK deputy Chief Veterinary Officer, and was agreed by BVA Council in April.
The report builds on BVA’s Brexit Principles, agreed by Council in September 2016, and covers seven areas of public policy: veterinary workforce, animal health, animal welfare, food hygiene and safety, veterinary medicines, research and development, and trade.
Two further sections of the report consider issues relating to devolution and to Northern Ireland’s unique position as the only part of the UK to share a land border with an EU member state.
With a snap General Election due in five weeks’ time, BVA has produced a 20-point manifesto of key recommendations covering both Brexit and wider policy issues, which has been sent to the main political parties’ manifesto-writing teams and to BVA’s Honorary Associates.
Brexit and the veterinary profession and the manifesto for the 2017 General Election are available at: www.bva.co.uk/brexit.